RT Journal Article
SR Electronic
T1 Pharmacotherapy of multiple sclerosis: current status
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 267
OP 277
VO 59
IS 3
A1 Richard A. Rudick
A1 Donald E. Goodkin
A1 Richard M. Ransohoff
YR 1992
UL http://www.ccjm.org/content/59/3/267.abstract
AB Pharmacotherapy plays an important part in the overall management of patients with multiple sclerosis. Most therapies directed at altering the natural history of the underlying disease process are only partially effective or are controversial or experimental. However, many effective symptomatic therapies are available to the clinician. The action and uses of corticosteroids in multiple sclerosis are discussed, and approaches to the treatment of spasticity, paroxysmal disorders, bladder dysfunction, cerebellar ataxia, neurobehavioral manifestations, fatigue, and acute and chronic pain in patients with multiple sclerosis are examined.